Liuyao Group announced that in the first half of 2026, it achieved operating income of 10.526 billion yuan, an increase of 2.19% year on year; net profit attributable to shareholders of listed companies was 369 million yuan, a decrease of 14.00% year on year. The increase in revenue and the lack of profit were mainly due to occasional effects of partial payment of preferential taxes and late payment fees. Combined, the collection and implementation of Chinese medicine tablets and traditional Chinese medicine formula granules affected the gross profit of the industrial side. Net operating cash flow during the reporting period was 136 million yuan, up 53.25% year on year; retail business revenue was 2.153 billion yuan, up 31.00% year on year.

Liuyao Group announced that in the first half of 2026, it achieved operating income of 10.526 billion yuan, an increase of 2.19% year on year; net profit attributable to shareholders of listed companies was 369 million yuan, a decrease of 14.00% year on year. The increase in revenue and the lack of profit were mainly due to occasional effects of partial payment of preferential taxes and late payment fees. Combined, the collection and implementation of Chinese medicine tablets and traditional Chinese medicine formula granules affected the gross profit of the industrial side. Net operating cash flow during the reporting period was 136 million yuan, up 53.25% year on year; retail business revenue was 2.153 billion yuan, up 31.00% year on year.